Production of Chinese vaccine in Serbia to commence in October - Cornerstone for the construction of factory laid on September 9

Minister of Health Zlatibor Loncar announced that the production of the Chinese vaccine against the COVID virus in Serbia will start in October, and that the company Hemofarm is expected to produce about six million doses by the end of the year.

As Loncar said at the Belgrade Nikola Tesla Airport, where he welcomed the first contingent of raw materials for the production of the Chinese vaccine, a cornerstone for the construction of a factory that will produce the vaccine will be laid on September 9.

- The deadline for the completion of construction works on the factory is the first quarter of next year, and around three million doses will be produced monthly - the Minister stated.

He added that "trial" production will last until October, and afterwards the "regular" production of the vaccine will commence.

- Those doses will be intended primarily for the citizens of Serbia, and if there is a surplus, it will be exported to the countries of the region - said Loncar.

Chinese Ambassador to Belgrade, Chen Bo reiterated that Serbia was the first country in Europe to use the Chinese vaccine against the COVID virus, and added that Serbia will soon become the first European country to produce that vaccine.

- This is a great new success for our cooperation in the fight against the epidemic - said the Chinese ambassador.

Ministarstvo zdravlja Republike Srbije

Hemofarm a.d. Vršac

Ambasada NR Kine Beograd

Cen Bo

Zlatibor Loncar

Production of Chinese vaccine

Sinofarm

Production of vaccine

COVID 19 vaccine

coronavirus